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Introduction
Chronic non-bacterial osteomyelitis (CNO) is today
included among the autoinflammatory bone diseases.
An alternative term in the literature is chronic recurrent
multifocal osteomyelitis (CRMO). The etiology of the
autoinflammatory bone diseases is unknown except for
a few extremely rare monogenic diseases.
Objectives
To describe a pediatric CNO cohort with respect to age
at onset, age at diagnosis, number and location of
lesions, imaging and treatment.
Patients and methods
Patients with CNO treated at the Queen Silvia Children’s
Hospital, Goteborg from 2000 to 2015. It is a retrospective
file review of patients diagnosed before the age of 18 years.
Results
Twenty-seven patients with CNO were identified. The
majority of the patients were females (22/27, 81%). The
median age at onset of symptoms were 8.6 years (range
4.3 to 16 years) and the median age at diagnosis were 11.2
years (range 5.3 to 17.8). In total 80 lesions were found in
the 27 patients. In 5 patients (19%) only one lesion was
found. Most frequently lesions were found in proximal
tibia (n=14), distal femur (n=11), clavicle (n=11), distal
tibia (n=10) and vertebral column (n=5).
A biopsy was performed in 24 patients and it con-
firmed osteomyelitis in 22 (92%). A microorganism was
identified in 6 cases, but was considered a non-signifi-
cant finding and not the etiology of the osteomyelitis.
Plain x-rays were performed in all patients. In addi-
tion, 21 (78%) patients had a bone scan, 16 (59%) a
MRT and 3 (11%) a whole body MRT.
Twelve patients (44%) were treated with antibiotics in
an early phase of the disease.
Almost all patients were treated with NSAID (n=25,
93%) and many with a short course of corticosteroids
(n=15, 59%). DMARDS were used in 14 patients includ-
ing methotrexate that was used in 13 patients (48%) and
sulfasalazine in 1 patient.
TNF inhibition was used in 6 patients and IL-1 block-
ade in 2 patients. Bisphosphonate was used in 3 patients.
Conclusions
In our cohort of patients with CNO there is a predomi-
nance of females. The median age of onset is 8.6 years.
There is a large diagnostic delay. About 1/5 of patients
had only one lesion which, makes the term CRMO pro-
blematic. The severity of CNO ranges from only one
mild lesion to a severe phenotype with many lesions.
Some patients only needed treatment with NSAIDs
while others required intense treatments with biologics
or bisphosphonates.
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